Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 4570

2.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
3.

Hereditary ovarian cancer.

Prat J, Ribé A, Gallardo A.

Hum Pathol. 2005 Aug;36(8):861-70. Review.

PMID:
16112002
5.

Managing hereditary ovarian cancer risk.

Berchuck A, Schildkraut JM, Marks JR, Futreal PA.

Cancer. 1999 Dec 1;86(11 Suppl):2517-24. Review.

PMID:
10630177
6.

Genetic susceptibility testing and prophylactic oophorectomy.

Berchuck A, Carney ME, Futreal PA.

Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):159-64. Review.

PMID:
10206409
7.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
8.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
9.

Should women with familial ovarian cancer undergo prophylactic oophorectomy?

Kerlikowske K, Brown JS, Grady DG.

Obstet Gynecol. 1992 Oct;80(4):700-7. Review.

PMID:
1407898
10.

Patterns of failure following surgical resection for malignant pleural mesothelioma.

Jänne PA, Baldini EH.

Thorac Surg Clin. 2004 Nov;14(4):567-73. Review.

PMID:
15559064
11.

Medical therapy of advanced malignant epithelial tumours of the ovary.

Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.

PMID:
11535983
12.

Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.

Berek JS, Chalas E, Edelson M, Moore DH, Burke WM, Cliby WA, Berchuck A; Society of Gynecologic Oncologists Clinical Practice Committee.

Obstet Gynecol. 2010 Sep;116(3):733-43. doi: 10.1097/AOG.0b013e3181ec5fc1. Review.

PMID:
20733460
13.
14.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
15.

Epidemiology of susceptibility to breast cancer.

Hulka BS.

Prog Clin Biol Res. 1996;395:159-74. Review.

PMID:
8895988
16.

A review of the epidemiology of human breast cancer.

Kelsey JL.

Epidemiol Rev. 1979;1:74-109. Review.

PMID:
398270
17.

[Adenocarcinoma of the prostate].

Dvorácek J.

Cas Lek Cesk. 1998 Aug 31;137(17):515-21. Review. Czech.

PMID:
9787503
18.

The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease.

Herbst AL.

Am J Obstet Gynecol. 1994 Apr;170(4):1099-105; discussion 1105-7. Review.

PMID:
8166193
19.

The role of prophylactic oophorectomy in cancer prevention.

Averette HE, Nguyen HN.

Gynecol Oncol. 1994 Dec;55(3 Pt 2):S38-41. Review.

PMID:
7835808
20.

The prevention of breast cancer through reduced ovarian steroid exposure.

Spicer DV, Pike MC.

Acta Oncol. 1992;31(2):167-74. Review.

PMID:
1622631

Supplemental Content

Support Center